{"id":"https://openalex.org/W2416865455","doi":"https://doi.org/10.1177/030089169307900108","title":"A Phase II Study of Combination Chemotherapy in Advanced Ovarian Carcinoma with Cisplatin and Cyclophosphamide plus Reduced Glutathione as Potential Protective Agent against Cisplatin Toxicity","display_name":"A Phase II Study of Combination Chemotherapy in Advanced Ovarian Carcinoma with Cisplatin and Cyclophosphamide plus Reduced Glutathione as Potential Protective Agent against Cisplatin Toxicity","publication_year":1993,"publication_date":"1993-02-01","ids":{"openalex":"https://openalex.org/W2416865455","doi":"https://doi.org/10.1177/030089169307900108","mag":"2416865455","pmid":"https://pubmed.ncbi.nlm.nih.gov/8497920"},"language":"en","primary_location":{"id":"doi:10.1177/030089169307900108","doi":"https://doi.org/10.1177/030089169307900108","is_oa":false,"landing_page_url":"https://doi.org/10.1177/030089169307900108","pdf_url":null,"source":{"id":"https://openalex.org/S4210189328","display_name":"Tumori Journal","issn_l":"0300-8916","issn":["0300-8916","2038-2529"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tumori Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087617291","display_name":"Maria Cristina Locatelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088346","display_name":"Azienda Ospedaliera Ospedale San Carlo Borromeo","ror":"https://ror.org/005s69p38","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210088346"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Cristina Locatelli","raw_affiliation_strings":["Medical Oncology Dept., San Carlo Borromeo Hospital, Milan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Dept., San Carlo Borromeo Hospital, Milan","institution_ids":["https://openalex.org/I4210088346"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112417269","display_name":"Adelaide D'Antona","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088346","display_name":"Azienda Ospedaliera Ospedale San Carlo Borromeo","ror":"https://ror.org/005s69p38","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210088346"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Adelaide D'Antona","raw_affiliation_strings":["Medical Oncology Dept., San Carlo Borromeo Hospital, Milan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Dept., San Carlo Borromeo Hospital, Milan","institution_ids":["https://openalex.org/I4210088346"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084773667","display_name":"Roberto Labianca","orcid":"https://orcid.org/0000-0001-7149-822X","observed_orcids":["https://orcid.org/0000-0001-7149-822X"]},"institutions":[{"id":"https://openalex.org/I4210088346","display_name":"Azienda Ospedaliera Ospedale San Carlo Borromeo","ror":"https://ror.org/005s69p38","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210088346"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Roberto Labianca","raw_affiliation_strings":["Medical Oncology Dept., San Carlo Borromeo Hospital, Milan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Dept., San Carlo Borromeo Hospital, Milan","institution_ids":["https://openalex.org/I4210088346"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Maria Vinci","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088346","display_name":"Azienda Ospedaliera Ospedale San Carlo Borromeo","ror":"https://ror.org/005s69p38","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210088346"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Vinci","raw_affiliation_strings":["Medical Oncology Dept., San Carlo Borromeo Hospital, Milan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Dept., San Carlo Borromeo Hospital, Milan","institution_ids":["https://openalex.org/I4210088346"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107518122","display_name":"Mich\u00e8le Tedeschi","orcid":"https://orcid.org/0000-0002-8554-495X","observed_orcids":["https://orcid.org/0000-0002-8554-495X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michele Tedeschi","raw_affiliation_strings":["Boehringer Mannheim Italia, Research Center, Monza (Milano)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Mannheim Italia, Research Center, Monza (Milano)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036335281","display_name":"Rosario Carcione","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088346","display_name":"Azienda Ospedaliera Ospedale San Carlo Borromeo","ror":"https://ror.org/005s69p38","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210088346"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Rosario Carcione","raw_affiliation_strings":["Gynecology Dept., San Carlo Borromeo Hospital, Milan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gynecology Dept., San Carlo Borromeo Hospital, Milan","institution_ids":["https://openalex.org/I4210088346"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066452790","display_name":"Antonello Corbo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088346","display_name":"Azienda Ospedaliera Ospedale San Carlo Borromeo","ror":"https://ror.org/005s69p38","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210088346"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Antonello Corbo","raw_affiliation_strings":["Gynecology Dept., San Carlo Borromeo Hospital, Milan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gynecology Dept., San Carlo Borromeo Hospital, Milan","institution_ids":["https://openalex.org/I4210088346"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067380273","display_name":"Paola Venturino","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paola Venturino","raw_affiliation_strings":["Boehringer Mannheim Italia, Research Center, Monza (Milano)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Mannheim Italia, Research Center, Monza (Milano)","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008585325","display_name":"Gino Luporini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088346","display_name":"Azienda Ospedaliera Ospedale San Carlo Borromeo","ror":"https://ror.org/005s69p38","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210088346"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Gino Luporini","raw_affiliation_strings":["Medical Oncology Dept., San Carlo Borromeo Hospital, Milan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Dept., San Carlo Borromeo Hospital, Milan","institution_ids":["https://openalex.org/I4210088346"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":0.6387,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.70360533,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"79","issue":"1","first_page":"37","last_page":"39"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9702000021934509,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9702000021934509,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":0.026200000196695328,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/advanced-ovarian-cancer","display_name":"advanced ovarian cancer","score":0.9779999852180481},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9909999966621399},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9449999928474426},{"id":"https://openalex.org/keywords/reduced-glutathione","display_name":"reduced glutathione","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7210000157356262},{"id":"https://openalex.org/keywords/nephrotoxicity","display_name":"nephrotoxicity","score":0.8560000061988831},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.9449999928474426},{"id":"https://openalex.org/keywords/drug-toxicity-protection","display_name":"drug toxicity protection","score":0.5009999871253967},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.8949999809265137},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.5979999899864197},{"id":"https://openalex.org/keywords/therapeutic-index","display_name":"therapeutic index","score":0.5350000262260437}],"concepts":[{"id":"https://openalex.org/C126189478","wikidata":"https://www.wikidata.org/wiki/Q1468324","display_name":"Nephrotoxicity","level":3,"score":0.7883051037788391},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.7407107949256897},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6733123064041138},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6343953609466553},{"id":"https://openalex.org/C538909803","wikidata":"https://www.wikidata.org/wiki/Q116907","display_name":"Glutathione","level":3,"score":0.6290066838264465},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.5933389067649841},{"id":"https://openalex.org/C3019054536","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian carcinoma","level":4,"score":0.5530717968940735},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5480787754058838},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.5276095867156982},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5189963579177856},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.47757771611213684},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.44449061155319214},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.44344696402549744},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4240551292896271},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41189679503440857},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3752999007701874},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.26271069049835205},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.14379683136940002},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005978","descriptor_name":"Glutathione","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/030089169307900108","doi":"https://doi.org/10.1177/030089169307900108","is_oa":false,"landing_page_url":"https://doi.org/10.1177/030089169307900108","pdf_url":null,"source":{"id":"https://openalex.org/S4210189328","display_name":"Tumori Journal","issn_l":"0300-8916","issn":["0300-8916","2038-2529"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tumori Journal","raw_type":"journal-article"},{"id":"pmid:8497920","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8497920","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tumori","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W156154009","https://openalex.org/W1978143683","https://openalex.org/W1980763729","https://openalex.org/W1988988098","https://openalex.org/W1992614799","https://openalex.org/W1994790143","https://openalex.org/W2167805334","https://openalex.org/W2286008868","https://openalex.org/W2471433311","https://openalex.org/W2474110094","https://openalex.org/W2914878951","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W1973967984","https://openalex.org/W1992614799","https://openalex.org/W2156533107","https://openalex.org/W2140464421","https://openalex.org/W2474110094","https://openalex.org/W2051521829","https://openalex.org/W2081964855","https://openalex.org/W2006613730","https://openalex.org/W156154009","https://openalex.org/W4242872483"],"abstract_inverted_index":{"AIMS":[0],"AND":[1],"BACKGROUND:":[2],"The":[3],"clinical":[4,178,208],"use":[5],"of":[6,10,58,122,155,161,196],"cisplatin":[7],"(CDDP),":[8],"one":[9],"the":[11,55,159,166,177,193],"most":[12],"active":[13],"agents":[14],"in":[15,102,176],"advanced":[16,44,73],"ovarian":[17,45,74],"cancer,":[18],"is":[19],"limited":[20],"by":[21,205],"nephrotoxicity":[22],"and":[23,67,137,143,188],"cumulative":[24],"neurotoxicity.":[25],"In":[26],"preclinical":[27],"studies,":[28],"reduced":[29],"glutathione":[30],"(GSH)":[31],"demonstrated":[32],"a":[33],"protective":[34,56],"action":[35,57],"against":[36,60],"CDDP":[37,50,61,186],"nephrotoxicity.":[38,62,156],"We":[39],"treated":[40],"20":[41,70],"patients":[42,128,139],"with":[43,47,72,129,165],"carcinoma,":[46],"polychemotherapy":[48],"containing":[49],"+":[51,88,97],"GSH,":[52,170],"to":[53,202],"assess":[54],"GSH":[59,98,180,190],"METHODS:":[63],"Between":[64],"January":[65],"1988":[66],"December":[68],"1989,":[69],"patients,":[71],"carcinoma":[75],"(St.":[76],"III-IV-FIGO),":[77],"not":[78],"pretreated":[79],"received":[80],"CDDP:":[81],"45":[82],"mg/m2":[83,92],"i.v.,":[84],"on":[85,94,185],"day":[86,95],"1-2,":[87],"cyclophosphamide":[89],"(CPA):":[90],"900":[91],"i.v.":[93,101],"2":[96],"2500":[99],"mg":[100],"normal":[103],"saline":[104],"100":[105],"ml":[106],"(in":[107],"15":[108],"min),":[109],"before":[110],"CDDP,":[111],"every":[112],"21-28":[113],"days.":[114],"RESULTS:":[115],"A":[116],"pathologic":[117],"complete":[118],"response":[119],"rate":[120],"(PCR)":[121],"55%":[123],"(11/20)":[124],"was":[125,134,150],"observed":[126],"(7/14":[127],"bulky":[130],"disease).":[131],"Median":[132],"survival":[133],"26.5":[135],"months":[136],"5":[138],"were":[140],"still":[141],"alive":[142],"disease":[144],"free":[145],"at":[146],"35":[147],"months.":[148],"Toxicity":[149],"limited,":[151],"without":[152,169],"any":[153],"case":[154],"CONCLUSIONS:":[157],"On":[158],"basis":[160],"our":[162,199],"previous":[163],"experience":[164],"same":[167],"regimen":[168],"this":[171],"study":[172],"suggests":[173],"that":[174,189],"also":[175],"setting,":[179],"has":[181],"no":[182],"negative":[183],"interference":[184],"activity":[187],"might":[191],"improve":[192],"therapeutic":[194],"index":[195],"CDDP.":[197],"However,":[198],"data":[200],"need":[201],"be":[203],"confirmed":[204],"large":[206],"randomized":[207],"studies.":[209]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}